Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NASDAQ: CRBP · Real-Time Price · USD
8.50
+0.04 (0.47%)
At close: Jul 18, 2025, 4:00 PM
8.89
+0.39 (4.59%)
After-hours: Jul 18, 2025, 7:57 PM EDT
CRBP Market Cap
CRBP has a market cap or net worth of $104.01 million as of July 18, 2025. Its market cap has decreased by -79.73% in one year.
Market Cap
104.01M
Enterprise Value
-25.92M
1-Year Change
-79.73%
Ranking
Category
Stock Price
$8.50
Market Cap Chart
Since November 11, 2014, CRBP's market cap has increased from $75.80M to $104.01M, an increase of 37.22%. That is a compound annual growth rate of 3.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 18, 2025 | 104.00M | -27.63% |
| Dec 31, 2024 | 143.70M | 438.20% |
| Dec 29, 2023 | 26.70M | 93.48% |
| Dec 30, 2022 | 13.80M | -82.10% |
| Dec 31, 2021 | 77.10M | -26.57% |
| Dec 31, 2020 | 105.00M | -70.26% |
| Dec 31, 2019 | 353.10M | 5.62% |
| Dec 31, 2018 | 334.30M | -14.19% |
| Dec 29, 2017 | 389.60M | 3.75% |
| Dec 30, 2016 | 375.50M | 505.65% |
| Dec 31, 2015 | 62.00M | -19.58% |
| Dec 31, 2014 | 77.10M | 1.72% |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 692.79B |
| Johnson & Johnson | 393.87B |
| AbbVie | 334.31B |
| Novo Nordisk | 287.38B |
| UnitedHealth Group | 256.40B |
| Novartis AG | 223.49B |
| Abbott Laboratories | 215.17B |
| AstraZeneca | 214.61B |